Shigellosis in Bay of Bengal Islands, India: Clinical and seasonal patterns, surveillance of antibiotic susceptibility patterns, and molecular characterization of multidrug-resistant Shigella strains isolated during a 6-year period from 2006 to 2011

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 33, Issue 2, 2014, Pages 157-170

  Bhattacharya, D ^a   Bhattacharya, H ^a   Thamizhmani, R ^a   Sayi, D S ^a   Reesu, R ^a   Anwesh, M ^a   Kartick, C ^a   Bharadwaj, A P ^b   Singhania, M ^c   Sugunan, A P ^a   Roy, S ^a  

^a GOVERNMENT OF INDIA   (India)

^b Chirayu Child Care Centre   (India)

^c G B PANT HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DYSENTERY, BACILLARY; EPIDEMIOLOGICAL MONITORING; FECES; FEMALE; FLUOROQUINOLONES; HUMANS; INDIA; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; SEASONS; SHIGELLA;

EID: 84893948588     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-013-1937-2     Document Type: Article

References (42)

1. Ahmed AM, Furuta K, Shimomura K, Kasama Y, Shimamoto T (2006) Genetic characterization of multidrug resistance in Shigella spp. from Japan. J Med Microbiol 55:1685-1691
2. Kotloff KL, Winickoff JP, Ivanoff B, Clemens JD, Swerdlow DL, Sansonetti PJ, Adak GK, Levine MM (1999) Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull World Health Organ 77:651-666
3. World Health Organization (WHO) (2005) Shigellosis: disease burden, epidemiology and case management. Wkly Epidemiol Rec 80:94-99
4. Christopher PR, David KV, John SM, Sankarapandian V (2009) Antibiotic therapy for Shigella dysentery. Cochrane Database Syst Rev (4):CD006784
5. Ashkenazi S, Levy I, Kazaronovski V, Samra Z (2003) Growing antimicrobial resistance of Shigella isolates. J Antimicrob Chemother 51:427-429
6. Bennish ML, Salam MA (1992) Rethinking options for the treatment of shigellosis. J Antimicrob Chemother 30:243-247
7. Zafar A, Hasan R, Nizami SQ, von Seidlein L, Soofi S, Ahsan T, Chandio S, Habib A, Bhutto N, Siddiqui FJ, Rizvi A, Clemens JD, Bhutta ZA (2009) Frequency of isolation of various subtypes and antimicrobial resistance of Shigella from urban slums of Karachi, Pakistan. Int J Infect Dis 13:668-672
8. Ghosh AR, Sehgal SC (1996) Existing status of shigellosis in Andaman & Nicobar Islands. Indian J Med Res 103:134-137
9. Roy S, Thanasekaran K, Dutta Roy AR, Sehgal SC (2006) Distribution of Shigella enterotoxin genes and secreted autotransporter toxin gene among diverse species and serotypes of Shigella isolated from Andaman Islands, India. Trop Med Int Health 11:1694-1698
10. Bhattacharya D, Sugunan AP, Bhattacharjee H, Thamizhmani R, Sayi DS, Thanasekaran K, Manimunda SP, Ghosh AR, Bharadwaj AP, Singhania M, Roy S (2012) Antimicrobial resistance in Shigella - rapid increase & widening of spectrum in Andaman Islands, India. Indian J Med Res 135:365-370
11. World Health Organization (WHO) (1987) Manual for laboratory investigation of acute enteric infections. CDD/83.3. WHO, Geneva, Switzerland
12. Clinical and Laboratory Standards Institute (CLSI) (2012) Performance standards for antimicrobial susceptibility testing; Twenty-second informational supplement. M100-S22. CLSI, Wayne, PA
13. Bhattacharya D, Sugunan AP, Bhattacharjee H, Thamizhmani R, Sudharama SD, Manimunda SP, Bharadwaj AP, Singhania M, Roy S (2011) Rapid emergence of third-generation cephalosporin resistance in Shigella sp. isolated in Andaman and Nicobar Islands, India. Microb Drug Resist 17:329-332
14. Pazhani GP, Niyogi SK, Singh AK, Sen B, Taneja N, Kundu M, Yamasaki S, Ramamurthy T (2008) Molecular characterization of multidrug-resistant Shigella species isolated from epidemic and endemic cases of shigellosis in India. J Med Microbiol 57:856-863
15. Talukder KA, Mondol AS, Islam MA, Islam Z, Dutta DK, Khajanchi BK, Azmi IJ, Hossain MA, Rahman M, Cheasty T, Cravioto A, Nair GB, Sack DA (2007) A novel serovar of Shigella dysenteriae from patients with diarrhoea in Bangladesh. J Med Microbiol 56:654-658
16. Dutta S, Kawamura Y, Ezaki T, Nair GB, Iida K, Yoshida S (2005) Alteration in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinolone-resistant Shigella dysenteriae serotype 1 clinical isolates from Kolkata, India. Antimicrob Agents Chemother 49:1660-1661
17. Kim HB, Park CH, Kim CJ, Kim EC, Jacoby GA, Hooper DC (2009) Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period. Antimicrob Agents Chemother 53:639-645
18. Fullá N, Prado V, Durán C, Lagos R, Levine MM (2005) Surveillance for antimicrobial resistance profiles among Shigella species isolated from a semirural community in the northern administrative area of Santiago, Chile. Am J Trop Med Hyg 72:851-854
19. von Seidlein L, Kim DR, Ali M, Lee H, Wang X, Thiem VD, Canh do G, Chaicumpa W, Agtini MD, Hossain A, Bhutta ZA, Mason C, Sethabutr O, Talukder K, Nair GB, Deen JL, Kotloff K, Clemens J (2006) A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology. PLoS Med 3(9):e353
20. Zhang W, Luo Y, Li J, Lin L, Ma Y, Hu C, Jin S, Ran L, Cui S (2011) Wide dissemination of multidrug-resistant Shigella isolates in China. J Antimicrob Chemother 66:2527-2535
21. World Health Organization (WHO) (2005) Guidelines for the control of shigellosis, including epidemics due to Shigella dysenteriae type 1. WHO, Geneva, Switzerland. Available online at: http://whqlibdoc.who.int/publications/ 2005/9241592330.pdf. Accessed 22nd Sep 2012
22. Niyogi SK (2007) Increasing antimicrobial resistance - an emerging problem in the treatment of shigellosis. Clin Microbiol Infect 13:1141-1143
23. Maraki S, Georgiladakis A, Christidou A, Scoulica E, Tselentis Y (1998) Antimicrobial susceptibilities and beta-lactamase production of Shigella isolates in Crete, Greece, during the period 1991-1995. APMIS 106:879-883
24. Egah DZ, Banwat EB, Audu ES, Allanana JA, Danung ML, Damen JG, Badung BP (2003) Multiple drug resistant strains of Shigella isolated in Jos, central Nigeria. Niger Postgrad Med J 10:154-156
25. Lee JC, Oh JY, Kim KS, Jeong YW, Cho JW, Park JC, Seol SY, Cho DT (2001) Antimicrobial resistance of Shigella sonnei in Korea during the last two decades. APMIS 109:228-234
26. Ashkenazi S, May-Zahav M, Sulkes J, Zilberberg R, Samra Z (1995) Increasing antimicrobial resistance of Shigella isolates in Israel during the period 1984 to 1992. Antimicrob Agents Chemother 39:819-823
27. Fortineau N, Naas T, Gaillot O, Nordmann P (2001) SHV-type extended-spectrum β-lactamase in a Shigella flexneri clinical isolate. J Antimicrob Chemother 47:685-688
28. Fasano A, Noriega FR, Liao FM, Wang W, Levine MM (1997) Effect of Shigella enterotoxin 1 (ShET1) on rabbit intestine in vitro and in vivo. Gut 40:505-511
29. Niyogi SK, Vargas M, Vila J (2004) Prevalence of the sat, set and sen genes among diverse serotypes of Shigella flexneri strains isolated from patients with acute diarrhoea. Clin Microbiol Infect 10:574-576
30. Briñas L, Zarazaga M, Sáenz Y, Ruiz-Larrea F, Torres C (2002) Beta-lactamases in ampicillin-resistant Escherichia coli isolates from foods, humans, and healthy animals. Antimicrob Agents Chemother 46(10):3156-3163
31. Huang IF, Chiu CH, Wang MH, Wu CY, Hsieh KS, Chiou CC (2005) Outbreak of dysentery associated with ceftriaxone-resistant Shigella sonnei: first report of plasmid-mediated CMY-2-type AmpC beta-lactamase resistance in S. sonnei. J Clin Microbiol 43:2608-2612
32. Martínez-Salazar JM, Alvarez G, Gómez-Eichelmann MC (1986) Frequency of four classes of tetracycline resistance determinants in Salmonella and Shigella spp. clinical isolates. Antimicrob Agents Chemother 30:630-631
33. Peirano G, Agersø Y, Aarestrup FM, dos Prazeres Rodrigues D (2005) Occurrence of integrons and resistance genes among sulphonamide-resistant Shigella spp. from Brazil. J Antimicrob Chemother 55:301-305
34. Chopra I, Roberts M (2001) Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev 65:232-260
35. Alekshun MN, Levy SB (2007) Molecular mechanisms of antibacterial multidrug resistance. Cell 128(6):1037-1050
36. Sáenz Y, Briñas L, Domínguez E, Ruiz J, Zarazaga M, Vila J, Torres C (2004) Mechanisms of resistance in multiple-antibiotic- resistant Escherichia coli strains of human, animal, and food origins. Antimicrob Agents Chemother 48(10):3996-4001
37. Moon DC, Seol SY, Gurung M, Jin JS, Choi CH, Kim J, Lee YC, Cho DT, Lee JC (2010) Emergence of a new mutation and its accumulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolones in Escherichia coli isolates. Int J Antimicrob Agents 35:76-79
38. Vrints M, Mairiaux E, Van Meervenne E, Collard JM, Bertrand S (2009) Surveillance of antibiotic susceptibility patterns among Shigella sonnei strains isolated in Belgium during the 18-year period 1990 to 2007. J Clin Microbiol 47:1379-1385
39. Ruiz J (2003) Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J Antimicrob Chemother 51:1109-1117
40. Talukder KA, Khajanchi BK, Islam MA, Dutta DK, Islam Z, Safa A, Khan GY, Alam K, Hossain MA, Malla S, Niyogi SK, Rahman M, Watanabe H, Nair GB, Sack DA (2004) Genetic relatedness of ciprofloxacin resistant Shigella dysenteriae type 1 strains isolated in south Asia. J Antimicrob Chemother 54:730-734
41. Gad GFM, Abd El-Ghafar F, El-Domany RAA, Hashem ZS (2010) Epidemiology and antimicrobial resistance of staphylococci isolated from different infectious diseases. Braz J Microbiol 41:333-344
42. Falsafi T, Ehsani A, Niknam V (2009) The role of active efflux in antibiotic-resistance of clinical isolates of Helicobacter pylori. Indian J Med Microbiol 27(4):335-340